College News

The University of Oklahoma Health Sciences has achieved its highest ranking ever in National Institutes of Health funding awarded for research. NIH funding increased to $75.2 million in the previous federal fiscal year, improving the campus’s ranking to 102 out of 2,838 institutions and other entities that receive NIH funding.

A new study published in Communications Medicine, a Nature publication, details the discovery of rare gene variants that increase the prevalence of Type 2 diabetes in multiple generations of Asian Indian people. The unusual finding is a step toward more targeted treatment for all people with Type 2 diabetes, a disease with complex genetic influences.

After a nationwide search, Dr. Isabella Grumbach, M.D., Ph.D., was named Chair of the Department of Internal Medicine at the University of Oklahoma College of Medicine and Clinical Service Chief at OU Health. In addition to her clinical responsibilities with OU Health, she will have educational and research responsibilities for the university, driving the academic health system’s three-part mission of clinical care, research and education.

A physician-scientist at the University of Oklahoma is part of an international effort seeking new options for patients with head and neck cancer who cannot receive the standard chemotherapy drug cisplatin.

After years of decreasing amputations in the United States, rates of non-traumatic lower extremity amputations due to diabetes and related conditions are rising, and Oklahoma is among the states with the most pronounced increase, a new University of Oklahoma study has found.